HKD 3.58
(-0.56%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 75.78 Million USD | -53.77% |
2022 | 163.93 Million USD | -31.88% |
2021 | 240.64 Million USD | 118.4% |
2020 | 110.18 Million USD | 343.88% |
2019 | 24.82 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 34.56 Million USD | 0.0% |
2024 Q1 | 34.56 Million USD | -54.39% |
2023 FY | 75.78 Million USD | -53.77% |
2023 Q2 | 123.83 Million USD | 0.0% |
2023 Q1 | 123.83 Million USD | -24.46% |
2023 Q4 | 75.78 Million USD | 0.0% |
2023 Q3 | 75.78 Million USD | -38.8% |
2022 Q2 | 210.76 Million USD | 0.0% |
2022 Q1 | 210.76 Million USD | -12.42% |
2022 FY | 163.93 Million USD | -31.88% |
2022 Q4 | 163.93 Million USD | 0.0% |
2022 Q3 | 163.93 Million USD | -22.22% |
2021 Q3 | 190.87 Million USD | 0.0% |
2021 FY | 240.64 Million USD | 118.4% |
2021 Q4 | 240.64 Million USD | 26.08% |
2021 Q1 | - USD | -100.0% |
2020 Q4 | 110.18 Million USD | 0.0% |
2020 FY | 110.18 Million USD | 343.88% |
2019 FY | 24.82 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | 81.515% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 99.326% |